Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment

Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment

Abstract Drug repositioning refers to new uses for existing drugs outside the scope of the original medical indications. This approach fastens the process of drug development allowing finding effective drugs with reduced side effects and lower costs. Colorectal cancer (CRC) is often diagnosed at adv...

Full description

Bibliographic Details
Main Authors: L. E. Anselmino, M. V. Baglioni, F. Malizia, N. Cesatti Laluce, C. Borini Etichetti, V. L. Martínez Marignac, V. Rozados, O. G. Scharovsky, J. Girardini, M. J. Rico, M. Menacho Márquez
Format: Article
Language:English
Published: Nature Publishing Group 2021-04-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-87525-z

Internet

https://doi.org/10.1038/s41598-021-87525-z

Similar Items